Multicenter Study Evaluating 12 Versus 24 Weeks Therapy With Peginterferon and Ribavirin for Hepatitis C Virus (HCV) Genotype 2 or 3
Clinical trial NCT00143000 · COMPLETED
Trial details
- NCT number
- NCT00143000
- Sponsor
- NORDynamIC Study Group
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.